Article
Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake.
Familial cancer - 1 Jan 2023
Ramsey Mitchell L, Tomlinson Jewel, Pearlman Rachel, Abushahin Laith, Aeilts Amber, Chen Hui-Zi, Chen Yan, Compton Ashley, Elkhatib Rifat, Geiger Levi, Hays John, Jeter Joanne, Jin Ning, Malalur Pannaga, Roychowdhury Sameek, Ruple Jessica, Prebish Jennifer, Stanich Peter P, Hampel Heather
Abstract excerpt
Germline genetic testing is recommended for all patients with pancreatic cancer (PC) but uptake rates are low. We implemented a mainstreaming program in oncology clinics to increase testing for PC patients. Genetic counselors trained oncology providers to offer a standardized multigene panel and obtain informed consent using an educational video. Pre-test genetic counseling was available upon request. Otherwise,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
